Cvs Health Insider Sold Shares Worth $253,695,413, According to a Recent SEC Filing-February 2024-www.financetom.com

Cvs Health Insider Sold Shares Worth $253,695,413, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Cvs Health Insider Sold Shares Worth $253,695,413, According to a Recent SEC Filing

May 26, 2025 2:18 AM

04:45 PM EDT, 05/06/2025 (MT Newswires) -- Larry Robbins, Director, on May 02, 2025, sold 3,750,000 shares in Cvs Health ( CVS ) for $253,695,413. Following the Form 4 filing with the SEC, Robbins has control over a total of 8,196,799 common shares of the company, with 8,196,799 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/64803/000090514825001466/xslF345X05/form4.xml

Previous page： Woodbridge Closes Sale of BlackJet Marketing, Inc. to Third Century Management, LLC Next page： TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Woodbridge Closes Sale of BlackJet Marketing, Inc. to Third Century Management, LLC

Oct 8, 2025

NEW HAVEN, Conn., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Woodbridge, a global mergers and acquisitions firm, and a Mariner company is pleased to announce the acquisition of its client, BlackJet Marketing, Inc. by Third Century Management, LLC. BlackJet Marketing, located in Mountain Top, Pennsylvania is a nationwide provider of direct mail marketing services, with a focus on travel, legal and...

TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout

Oct 8, 2025

TransCode Therapeutics Inc. ( RNAZ ) announced on Wednesday that it has entered a definitive agreement to acquire Polynoma LLC, a privately held biotechnology firm focused on immuno-oncology. The acquisition adds Polynoma's lead candidate, seviprotimut-L, a novel polyvalent shed antigen vaccine being developed for the adjuvant treatment of stage IIB and IIC melanoma, to TransCode's development pipeline. Under the terms...

Critical Metals (CRML) Stock Is Surging Wednesday: What's Going On?

Oct 8, 2025

Shares of Critical Metals Corp ( CRML ) are trading sharply higher Wednesday morning. The surge follows the announcement of an offtake agreement with REalloys, a U.S.-based rare earth processor. Here’s what investors need to know. What To Know: Under the terms of the new letter of intent, Critical Metals will supply REalloys with 15% of the annual rare earth...

E.l.f. Beauty's Rhode Brand Shows 'Clear' Consumer Appeal, 'Strong' Launch Execution, Morgan Stanley Says

Oct 8, 2025

10:46 AM EDT, 10/08/2025 (MT Newswires) -- E.l.f. Beauty's (ELF) rhode skincare brand shows clear consumer appeal, strong launch execution, and broadens the company's reach into prestige beauty, Morgan Stanley said in a Wednesday note. The brokerage said it raised its earnings per share estimates for the company by 1-2% for the second half of fiscal 2026 and fiscal 2027...